KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Merck (MRK) over the last 15 years, with Q3 2025 value amounting to $7.7 billion.

  • Merck's Other Non-Current Liabilities rose 160.48% to $7.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 billion, marking a year-over-year increase of 160.48%. This contributed to the annual value of $6.5 billion for FY2024, which is 2646.72% down from last year.
  • Merck's Other Non-Current Liabilities amounted to $7.7 billion in Q3 2025, which was up 160.48% from $7.0 billion recorded in Q2 2025.
  • In the past 5 years, Merck's Other Non-Current Liabilities registered a high of $12.2 billion during Q1 2021, and its lowest value of $6.5 billion during Q4 2024.
  • For the 5-year period, Merck's Other Non-Current Liabilities averaged around $8.4 billion, with its median value being $8.3 billion (2024).
  • Per our database at Business Quant, Merck's Other Non-Current Liabilities surged by 598.27% in 2021 and then crashed by 2646.72% in 2024.
  • Quarter analysis of 5 years shows Merck's Other Non-Current Liabilities stood at $9.4 billion in 2021, then dropped by 11.78% to $8.3 billion in 2022, then grew by 5.63% to $8.8 billion in 2023, then dropped by 26.47% to $6.5 billion in 2024, then increased by 18.5% to $7.7 billion in 2025.
  • Its last three reported values are $7.7 billion in Q3 2025, $7.0 billion for Q2 2025, and $6.7 billion during Q1 2025.